Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -105.20%, near the high end of its 5-year range (-1584.72%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-81.38%
NET PROFIT MARGIN AVG 5Y
-105.20%
NET PROFIT MARGIN AVG 10Y
-67.61%
NET PROFIT MARGIN AVG 15Y
-19.24%
NET PROFIT MARGIN AVG 20Y
-0.80%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Market Cap
$40.94M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$39.15M
Net Profit Margin
-689.20%
TTM Avg
-248.90%
3Y Avg
-225.94%
5Y Avg
-1945.52%
Market Cap
$38.87M
Net Profit Margin
8.38%
TTM Avg
3.43%
3Y Avg
-19.55%
5Y Avg
-29.01%
Market Cap
$41.92M
Net Profit Margin
-4.42%
TTM Avg
-14.19%
3Y Avg
-49.13%
5Y Avg
-77.93%
Market Cap
$38.47M
Net Profit Margin
-11.86%
TTM Avg
-39.34%
3Y Avg
-22.53%
5Y Avg
-16.34%
Market Cap
$42.38M
Net Profit Margin
-13.86%
TTM Avg
-1.65%
3Y Avg
-39.69%
5Y Avg
-47.80%
Market Cap
$42.46M
Net Profit Margin
-84.93%
TTM Avg
-105.50%
3Y Avg
-125.06%
5Y Avg
-177.30%
Market Cap
$42.81M
Net Profit Margin
-747.20%
TTM Avg
-525.22%
3Y Avg
-722.73%
5Y Avg
-1271.67%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Veru Inc. (VERU) | $40.31M | 0.00% | 0.00% | -81.38% | -105.20% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.15M | -689.20% | -248.90% | -225.94% | -1945.52% |
| Nephros, Inc. (NEPH)vs › | $38.87M | 8.38% | 3.43% | -19.55% | -29.01% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -4.42% | -14.19% | -49.13% | -77.93% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.47M | -11.86% | -39.34% | -22.53% | -16.34% |
| BioStem Technologies, Inc. (BSEM)vs › | $42.38M | -13.86% | -1.65% | -39.69% | -47.80% |
| CVRx, Inc. (CVRX)vs › | $42.46M | -84.93% | -105.50% | -125.06% | -177.30% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.81M | -747.20% | -525.22% | -722.73% | -1271.67% |
| Incannex Healthcare Limited (IXHL)vs › | $37.75M | 0.00% | -27258.72% | -52085.61% | -35139.97% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | -128.15% |
| 2024-06-30 | -277.42% |
| 2024-03-31 | -242.45% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | -210.57% |
| 2023-06-30 | -199.34% |
| 2023-03-31 | -513.04% |
| 2022-12-31 | -1543.55% |
| 2022-09-30 | -1584.72% |
| 2022-06-30 | -231.15% |
| 2022-03-31 | -108.82% |
| 2021-12-31 | -45.14% |
| 2021-09-30 | -27.45% |
| 2021-06-30 | -15.25% |
| 2021-03-31 | -21.33% |
| 2020-12-31 | 117.86% |
| 2020-09-30 | -100.71% |
| 2020-06-30 | -29.31% |
| 2020-03-31 | -8.15% |
| 2019-12-31 | -31.24% |
| 2019-09-30 | -35.06% |
| 2019-06-30 | -28.52% |
| 2019-03-31 | -57.83% |
| 2018-12-31 | -33.72% |
| 2018-09-30 | -152.20% |
| 2018-06-30 | -144.15% |
| 2018-03-31 | -148.91% |
| 2017-12-31 | -164.58% |
| 2017-09-30 | -72.56% |
| 2017-06-30 | -18.31% |
| 2017-03-31 | -73.86% |
| 2016-12-31 | -42.12% |
| 2016-09-30 | -49.14% |
| 2016-06-30 | 10.26% |
| 2016-03-31 | 0.73% |
| 2015-12-31 | 18.11% |
| 2015-09-30 | 9.82% |
| 2015-06-30 | 14.99% |
| 2015-03-31 | 15.19% |
| 2014-12-31 | 12.09% |
| 2014-09-30 | -10.19% |
| 2014-06-30 | 14.68% |
| 2014-03-31 | 8.63% |
| 2013-12-31 | 21.89% |
| 2013-09-30 | 137.61% |
| 2013-06-30 | 9.98% |
| 2013-03-31 | 36.84% |
| 2012-12-31 | 35.66% |
| 2012-09-30 | 82.58% |
| 2012-06-30 | 29.46% |
| 2012-03-31 | 24.32% |
| 2011-12-31 | 30.81% |
| 2011-09-30 | 63.51% |
| 2011-06-30 | 11.85% |
| 2011-03-31 | 1.89% |
| 2010-12-31 | 10.59% |
| 2010-09-30 | 70.72% |
| 2010-06-30 | 4.28% |
| 2010-03-31 | 25.69% |
| 2009-12-31 | -12.72% |
| 2009-09-30 | 28.81% |
| 2009-06-30 | 9.30% |
| 2009-03-31 | 26.98% |
| 2008-12-31 | 30.56% |
| 2008-09-30 | 30.17% |
| 2008-06-30 | 9.56% |
| 2008-03-31 | 18.84% |
| 2007-12-31 | 14.90% |
| 2007-09-30 | 22.53% |
| 2007-06-30 | 7.73% |
| 2007-03-31 | 6.71% |
| 2006-12-31 | -4.44% |
| 2006-09-30 | 2.10% |
| 2006-06-30 | 0.39% |
| 2006-03-31 | 2.06% |
| 2005-12-31 | 2.95% |
| 2005-09-30 | -2.99% |
| 2005-06-30 | -6.39% |
| 2005-03-31 | 2.82% |
| 2004-12-31 | -76.50% |
| 2004-09-30 | -41.51% |
| 2004-06-30 | -0.68% |
| 2004-03-31 | -32.23% |
| 2003-12-31 | -28.01% |
| 2003-09-30 | -35.23% |
| 2003-06-30 | -8.25% |
| 2003-03-31 | -53.20% |
| 2002-12-31 | -21.55% |
| 2002-09-30 | -13.71% |
